nitrates has been researched along with Proteinuria in 49 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis." | 7.72 | NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. ( Daig, U; Krämer, S; Liefeldt, L; Martini, S; Neumayer, HH; Peters, H; Rückert, M; Schäper, F, 2003) |
| " Here we assess the therapeutic effect of L-arginine supplementation, which has been shown to reduce fibrosis in a number of hypertensive models, given alone or in combination with low protein diet and started 24 hours after disease induction." | 7.70 | Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. ( Border, WA; Noble, NA; Peters, H, 2000) |
| "The present study was performed to test the hypothesis that excretion of nitric oxide metabolites, nitrate and nitrite, are decreased with progressive aging in rats and that a decrease in nitric oxide precursor, L-arginine, also decreases with aging." | 7.69 | Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. ( Bacon, EE; Blanchard, EJ; Kellum, JA; Kruckeberg, WC; Reckelhoff, JF; Wesley, AJ, 1994) |
| "Proteinuria was significantly lower in L-arginine-treated animals from week 24 onward (p<0." | 5.32 | Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure. ( Albrecht, EW; Smit-van Oosten, A; Stegeman, CA; van Goor, H, 2003) |
| "Supplementation with L-arginine (ARG) strikingly ameliorates proteinuria and glomerulosclerosis in remnant rats by overcoming nitric oxide (NO) deficiency." | 5.09 | Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. ( Andreucci, M; Andreucci, VE; Bellizzi, V; Capuano, A; Cianciaruso, B; Corso, G; De Nicola, L; Garibotto, G; Minutolo, R, 1999) |
| " The evolution of systolic blood pressure was followed by weekly measurements, and morphological variables, proteinuria, plasma nitrates plus nitrites (NOx) and thiobarbituric acid reactive substances (TBARS), liver oxidative stress markers and endothelial function were determined at the end of the experimental period." | 3.73 | Effects of chronic quercetin treatment in experimental renovascular hypertension. ( Bermejo, A; Duarte, J; Galisteo, M; García-Saura, MF; Vargas, F; Villar, IC; Zarzuelo, A, 2005) |
| " However, nipradilol, at doses of 10 and 15 mg/kg/day, significantly decreased proteinuria and glomerulosclerosis, while propranolol did not." | 3.72 | A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol. ( Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y, 2003) |
| "NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis." | 3.72 | NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. ( Daig, U; Krämer, S; Liefeldt, L; Martini, S; Neumayer, HH; Peters, H; Rückert, M; Schäper, F, 2003) |
| " Urinary excretion of Na and NO metabolites (NOx), as well as immunodetectable endothelial (eNOS), inducible (iNOS) and neuronal (nNOS) NO synthases were determined in rats with puromycin aminonucleoside (PAN)-induced NS, rats with protein overload proteinuria, Nagase rats (NAR) with inherited analbuminemia, iNOS inhibitor (aminoguanidine)-treated rats, prenephrotic PAN-treated and placebo-treated control rats." | 3.72 | Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria. ( Ni, Z; Vaziri, ND, 2003) |
| "Twenty-one days after 5/6 nephrectomy, after the onset of hypertension and overt proteinuria, rats were divided in 3 groups (N= 7-8) and given daily by gavage: vehicle, the vasopeptidase inhibitor AVE7688 (3 mg/kg bid), or enalapril (5 mg/kg bid) until day 90." | 3.72 | Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. ( Benigni, A; Corna, D; Longaretti, L; Maggioni, P; Noris, M; Remuzzi, G; Rottoli, D; Todeschini, M; Zatelli, C; Zoja, C, 2004) |
| "To explore the effects of ligustrazine on proteinuria, urinary TxB2 (metabolism of thromboxane A2, TxA2) and 6-keto-PGF1alpha (metabolism of prostacyclines I2, PG I2), glomerular inducible nitric oxide(NO) synthase (iNOS) mRNA, urinary NO3-/NO2- (decomposing products of NO) and pathological changes in rats with passive Heymann nephritis (PHN)." | 3.72 | Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis. ( Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J, 2004) |
| " Urinary samples with positive (at least one +) proteinuria, hematuria, leucocyturia, or nitrates using the Multistix strip were excluded from the study." | 3.71 | Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. ( Le Floch, JP; Marre, M; Passa, P; Rodier, M, 2001) |
| " Here we assess the therapeutic effect of L-arginine supplementation, which has been shown to reduce fibrosis in a number of hypertensive models, given alone or in combination with low protein diet and started 24 hours after disease induction." | 3.70 | Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. ( Border, WA; Noble, NA; Peters, H, 2000) |
| "The present study was performed to test the hypothesis that excretion of nitric oxide metabolites, nitrate and nitrite, are decreased with progressive aging in rats and that a decrease in nitric oxide precursor, L-arginine, also decreases with aging." | 3.69 | Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. ( Bacon, EE; Blanchard, EJ; Kellum, JA; Kruckeberg, WC; Reckelhoff, JF; Wesley, AJ, 1994) |
| "Aging is associated with loss of nephron function and reductions in serum L-arginine and excretion of nitric oxide (NO) metabolites." | 3.69 | Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function. ( Hildebrandt, DA; Kellum, JA; Racusen, LC; Reckelhoff, JF, 1997) |
| "Reduced bioavailability of endogenous nitric oxide (NO) is a central pathophysiological event in hypertension and other cardiovascular diseases." | 1.37 | Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. ( Carlström, M; Hezel, M; Larsson, E; Lundberg, JO; Persson, AE; Scheffer, PG; Teerlink, T; Weitzberg, E, 2011) |
| " Chronic administration of L-NAME for 8 wk induced hypertension and renal injury and reduced the blood iron-nitrosyl-hemoglobin level (control 38." | 1.35 | Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats. ( Ishizawa, K; Izawa, Y; Kagami, S; Kanematsu, Y; Kawazoe, K; Kondo, S; Motobayashi, Y; Ohnishi, H; Tamaki, T; Tomita, S; Tsuchiya, K; Yamaguchi, K, 2008) |
| "Diabetic nephropathy was exacerbated drastically by a nitric oxide synthase inhibitor and mildly by a NO precursor." | 1.33 | Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. ( Higuchi, M; Hora, K; Kamijo, H, 2006) |
| "Proteinuria was significantly lower in L-arginine-treated animals from week 24 onward (p<0." | 1.32 | Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure. ( Albrecht, EW; Smit-van Oosten, A; Stegeman, CA; van Goor, H, 2003) |
| "The beneficial effects of MMF on lupus nephritis during the early phase of the disease might be partly attributed to the inhibition of NO production." | 1.31 | Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. ( Chan, KW; Chan, TM; Fung, PC; Lai, KN; Lui, SL; Tsang, R; Wong, D, 2002) |
| "Proteinuria was within normal limits in all groups studied but L-arg caused a significant decrease in this parameter in both the RA8 and RA12 groups." | 1.31 | L-Arginine effects on blood pressure and renal function of intrauterine restricted rats. ( Alves, GM; Barão, MA; Brandizzi, LI; Franco Md, Mdo C; Laurindo, FR; Lucas, SR; Nascimento Gomes, G; Nigro, D; Odo, LN; Zaladek Gil, F, 2002) |
| "It is concluded that chronic renal failure in rats is a low nitric oxide production state." | 1.29 | Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. ( Ashab, I; Blum, M; Cabili, S; Chernihovsky, T; Hassner, A; Iaina, A; Peer, G; Schwartz, D; Silverberg, D; Wollman, Y, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.16) | 18.7374 |
| 1990's | 12 (24.49) | 18.2507 |
| 2000's | 27 (55.10) | 29.6817 |
| 2010's | 6 (12.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kmet, T | 1 |
| Filipets, N | 1 |
| Hrachova, T | 1 |
| Bulyk, T | 1 |
| Kushnir, O | 1 |
| Pye, C | 1 |
| Elsherbiny, NM | 1 |
| Ibrahim, AS | 1 |
| Liou, GI | 1 |
| Chadli, A | 1 |
| Al-Shabrawey, M | 1 |
| Elmarakby, AA | 1 |
| Ohigashi, M | 1 |
| Imai, N | 1 |
| Toba, H | 1 |
| Kobara, M | 1 |
| Nakata, T | 1 |
| Kanematsu, Y | 1 |
| Yamaguchi, K | 1 |
| Ohnishi, H | 1 |
| Motobayashi, Y | 1 |
| Ishizawa, K | 1 |
| Izawa, Y | 1 |
| Kawazoe, K | 1 |
| Kondo, S | 1 |
| Kagami, S | 1 |
| Tomita, S | 1 |
| Tsuchiya, K | 1 |
| Tamaki, T | 1 |
| Newaz, M | 1 |
| Yousefipour, Z | 1 |
| Oyekan, A | 1 |
| Carlström, M | 1 |
| Persson, AE | 1 |
| Larsson, E | 1 |
| Hezel, M | 1 |
| Scheffer, PG | 1 |
| Teerlink, T | 1 |
| Weitzberg, E | 1 |
| Lundberg, JO | 1 |
| Griffin, K | 1 |
| Polichnowski, A | 1 |
| Licea-Vargas, H | 1 |
| Picken, M | 1 |
| Long, J | 1 |
| Williamson, G | 1 |
| Bidani, A | 1 |
| Wagner, L | 1 |
| Riggleman, A | 1 |
| Erdely, A | 1 |
| Couser, W | 1 |
| Baylis, C | 1 |
| Lui, SL | 1 |
| Tsang, R | 1 |
| Wong, D | 1 |
| Chan, KW | 1 |
| Chan, TM | 1 |
| Fung, PC | 1 |
| Lai, KN | 1 |
| Alves, GM | 1 |
| Barão, MA | 1 |
| Odo, LN | 1 |
| Nascimento Gomes, G | 1 |
| Franco Md, Mdo C | 1 |
| Nigro, D | 1 |
| Lucas, SR | 1 |
| Laurindo, FR | 1 |
| Brandizzi, LI | 1 |
| Zaladek Gil, F | 1 |
| Ogawa, D | 1 |
| Shikata, K | 2 |
| Matsuda, M | 1 |
| Okada, S | 1 |
| Usui, H | 1 |
| Wada, J | 2 |
| Taniguchi, N | 1 |
| Makino, H | 3 |
| Albrecht, EW | 1 |
| van Goor, H | 2 |
| Smit-van Oosten, A | 1 |
| Stegeman, CA | 1 |
| Takamitsu, Y | 1 |
| Nakanishi, T | 1 |
| Nishihara, F | 1 |
| Hasuike, Y | 1 |
| Izumi, M | 1 |
| Inoue, T | 1 |
| Hiraoka, K | 1 |
| Itahana, R | 1 |
| Miyagawa, K | 1 |
| Rodríguez-Gómez, I | 1 |
| Sainz, J | 1 |
| Wangensteen, R | 1 |
| Moreno, JM | 1 |
| Duarte, J | 2 |
| Osuna, A | 1 |
| Vargas, F | 2 |
| Peters, H | 2 |
| Daig, U | 1 |
| Martini, S | 1 |
| Rückert, M | 1 |
| Schäper, F | 1 |
| Liefeldt, L | 1 |
| Krämer, S | 1 |
| Neumayer, HH | 1 |
| Ni, Z | 1 |
| Vaziri, ND | 1 |
| Celik, O | 1 |
| Hascalik, S | 1 |
| Turkoz, Y | 1 |
| Hascalik, M | 1 |
| Gokdeniz, R | 1 |
| Kim, HY | 1 |
| Yokozawa, T | 2 |
| Cho, EJ | 1 |
| Yamabe, N | 2 |
| Benigni, A | 1 |
| Zoja, C | 1 |
| Zatelli, C | 1 |
| Corna, D | 1 |
| Longaretti, L | 1 |
| Rottoli, D | 1 |
| Maggioni, P | 1 |
| Todeschini, M | 1 |
| Noris, M | 1 |
| Remuzzi, G | 1 |
| Wang, Y | 2 |
| Tong, J | 2 |
| Tang, R | 1 |
| Dong, H | 1 |
| Xu, J | 3 |
| García-Saura, MF | 1 |
| Galisteo, M | 1 |
| Villar, IC | 1 |
| Bermejo, A | 1 |
| Zarzuelo, A | 1 |
| Pedraza-Chaverrí, J | 1 |
| Barrera, D | 1 |
| Medina-Campos, ON | 1 |
| Carvajal, RC | 1 |
| Hernández-Pando, R | 1 |
| Macías-Ruvalcaba, NA | 1 |
| Maldonado, PD | 1 |
| Salcedo, MI | 1 |
| Tapia, E | 1 |
| Saldívar, L | 1 |
| Castilla, ME | 1 |
| Ibarra-Rubio, ME | 1 |
| Xia, CF | 1 |
| Bledsoe, G | 1 |
| Chao, L | 1 |
| Chao, J | 1 |
| Chander, V | 1 |
| Chopra, K | 1 |
| He, Q | 1 |
| Qin, H | 1 |
| Gao, L | 1 |
| Datta, PK | 1 |
| Duann, P | 1 |
| Lianos, EA | 1 |
| Kamijo, H | 1 |
| Higuchi, M | 1 |
| Hora, K | 1 |
| Kang, KS | 1 |
| Goto, E | 1 |
| Tanaka, T | 1 |
| Namikoshi, T | 1 |
| Tomita, N | 1 |
| Fujimoto, S | 1 |
| Haruna, Y | 1 |
| Ohzeki, M | 1 |
| Komai, N | 1 |
| Sasaki, T | 1 |
| Yoshida, A | 1 |
| Kashihara, N | 1 |
| Ashab, I | 1 |
| Peer, G | 2 |
| Blum, M | 1 |
| Wollman, Y | 2 |
| Chernihovsky, T | 2 |
| Hassner, A | 1 |
| Schwartz, D | 1 |
| Cabili, S | 1 |
| Silverberg, D | 1 |
| Iaina, A | 2 |
| Reckelhoff, JF | 3 |
| Kellum, JA | 2 |
| Blanchard, EJ | 1 |
| Bacon, EE | 1 |
| Wesley, AJ | 1 |
| Kruckeberg, WC | 1 |
| Gilkeson, GS | 1 |
| Ruiz, P | 1 |
| Pippen, AM | 1 |
| Alexander, AL | 1 |
| Lefkowith, JB | 1 |
| Pisetsky, DS | 1 |
| Lubarsky, SL | 1 |
| Ahokas, RA | 1 |
| Friedman, SA | 1 |
| Sibai, BM | 1 |
| Racusen, LC | 1 |
| Hildebrandt, DA | 1 |
| Hertzan-Levy, S | 1 |
| Yagil, C | 1 |
| Yagil, Y | 1 |
| Skutelsky, E | 1 |
| Chen, A | 2 |
| Sheu, LF | 2 |
| Chou, WY | 2 |
| Ho, YS | 2 |
| Lin, YF | 2 |
| Lin, FG | 1 |
| Lee, WH | 2 |
| Heeringa, P | 1 |
| Moshage, H | 1 |
| Klok, PA | 1 |
| Huitema, MG | 1 |
| de Jager, A | 1 |
| Schep, AJ | 1 |
| Kallenberg, CG | 1 |
| Chou, TC | 1 |
| De Nicola, L | 1 |
| Bellizzi, V | 1 |
| Minutolo, R | 1 |
| Andreucci, M | 1 |
| Capuano, A | 1 |
| Garibotto, G | 1 |
| Corso, G | 1 |
| Andreucci, VE | 1 |
| Cianciaruso, B | 1 |
| Sugimoto, H | 1 |
| Horiuchi, S | 1 |
| Kakoki, M | 1 |
| Matsumoto, A | 1 |
| Nagata, D | 1 |
| Kobayakawa, N | 1 |
| Kimura, K | 1 |
| Momomura, S | 1 |
| Hirata, Y | 1 |
| Border, WA | 1 |
| Noble, NA | 1 |
| Le Floch, JP | 1 |
| Marre, M | 1 |
| Rodier, M | 1 |
| Passa, P | 1 |
| Kataoka, H | 1 |
| Otsuka, F | 1 |
| Ogura, T | 1 |
| Yamauchi, T | 1 |
| Kishida, M | 1 |
| Takahashi, M | 1 |
| Mimura, Y | 1 |
| Alexander, BT | 1 |
| Kassab, SE | 1 |
| Miller, MT | 1 |
| Abram, SR | 1 |
| Bennett, WA | 1 |
| Granger, JP | 1 |
| Kyle, RA | 1 |
| Shampo, MA | 1 |
| Herbertson, BM | 1 |
| King, AJ | 1 |
| Allen, J | 1 |
| Bailey, CB | 1 |
| Angelova, O | 1 |
| Makaveeva, V | 1 |
1 trial available for nitrates and Proteinuria
| Article | Year |
|---|---|
Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure.
Topics: Adolescent; Adult; Amino Acids; Arginine; Cyclic GMP; Double-Blind Method; Female; Glomerular Filtra | 1999 |
48 other studies available for nitrates and Proteinuria
| Article | Year |
|---|---|
CHANGES OF PROTEINURIA AND ACID-REGULATING KIDNEY FUNCTION IN MATURE RATS WITH SLOW AND RAPID ACETYLATION TYPE UNDER CONDITIONS OF SUBACUTE CADMIUM-NITRATE INTOXICATION.
Topics: Acetylation; Acid-Base Equilibrium; Animals; Cadmium Chloride; Dose-Response Relationship, Drug; Kid | 2018 |
Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms.
Topics: Adenosine Kinase; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cell Line; Dextran | 2014 |
Pitavastatin Exhibits Protective Effects on Podocytes Accompanied by BMP-7 Up-Regulation and Rho Suppression.
Topics: Animals; Bone Morphogenetic Protein 7; Chemokine CCL2; Creatinine; Diabetes Mellitus, Experimental; | 2016 |
Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats.
Topics: Administration, Oral; Animals; Blood Pressure; Body Weight; Diet; Glycated Hemoglobin; Hypertension; | 2008 |
Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Administrat | 2010 |
Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension.
Topics: Animals; Arginine; Blood Pressure; Cardiomegaly; Disease Models, Animal; Hypertension, Renal; Kidney | 2011 |
Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.
Topics: Animals; Blood Pressure; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nit | 2012 |
Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis.
Topics: Animals; Antibodies; Arginine; Autoantibodies; Blood Urea Nitrogen; Creatinine; Glomerulonephritis; | 2002 |
Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
Topics: Animals; Female; Gene Expression Regulation, Enzymologic; Immunosuppressive Agents; Kidney; Lupus Ne | 2002 |
L-Arginine effects on blood pressure and renal function of intrauterine restricted rats.
Topics: Animals; Arginine; Blood Pressure; Female; Food Deprivation; Glomerular Filtration Rate; Kidney; Kid | 2002 |
Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats.
Topics: Amidines; Animals; Disease Progression; Enzyme Inhibitors; Glomerulonephritis; Heterocyclic Compound | 2002 |
Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure.
Topics: Animals; Arginine; Blood Pressure; Creatine; Dietary Supplements; Disease Models, Animal; Glomerulos | 2003 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Di | 2003 |
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.
Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Enzyme Inhibitors; Heart Rate; Hyperthyroidism; | 2003 |
NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Topics: Animals; Arginine; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibronectins; Fibrosis; Gene Expr | 2003 |
Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria.
Topics: Animals; Chlorides; Creatinine; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Enzy | 2003 |
Cerebrospinal fluid nitric oxide level changes in preeclampsia.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Birth Weight; Blood Pressure; Female; Gest | 2003 |
Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress.
Topics: Animals; Blood Glucose; Blood Proteins; Creatinine; Diabetes Mellitus, Experimental; Disease Models, | 2004 |
Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cyclic G | 2004 |
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; | 2004 |
Effects of chronic quercetin treatment in experimental renovascular hypertension.
Topics: Animals; Antioxidants; Aorta; Blood Pressure; Body Weight; Diet; Disease Models, Animal; Dose-Respon | 2005 |
Time course study of oxidative and nitrosative stress and antioxidant enzymes in K2Cr2O7-induced nephrotoxicity.
Topics: Acetylglucosaminidase; Animals; Catalase; Chromium; Creatine; Glutathione Peroxidase; Immunohistoche | 2005 |
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Topics: Animals; Cell Cycle Proteins; Cell Division; Cyclic GMP; Cyclin-Dependent Kinase Inhibitor p27; Deso | 2005 |
Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Pressure; Body Weight; Disease Models, Animal; Eat | 2006 |
The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis.
Topics: Animals; Cells, Cultured; Complement Membrane Attack Complex; Enzyme Inhibitors; Glomerular Mesangiu | 2006 |
Long-term effect of heme oxygenase (HO)-1 induction in glomerular immune injury.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Blood Pressure; Blood Urea Nitrogen; Creatinine; | 2006 |
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glom | 2006 |
Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Blotting, Western; Cornus; Creatinine; Diabetes Mellit | 2007 |
Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in Dahl salt-sensitive rats.
Topics: Animals; Antioxidants; Blood Pressure; Blotting, Western; Cyclopentanes; Humulus; Hypertension; Kidn | 2007 |
Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production.
Topics: Administration, Oral; Animals; Arginine; Blood Pressure; Captopril; Creatinine; Female; Kidney Failu | 1995 |
Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging.
Topics: Aging; Animals; Arginine; Fasting; Glomerular Filtration Rate; Male; Nitrates; Nitric Oxide; Nitrite | 1994 |
Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
Topics: Animals; DNA, Bacterial; Escherichia coli; Immunization; Immunoglobulin G; Kidney Glomerulus; Lupus | 1996 |
The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Inhibitors; Female; Guanidines; Heart Rate; Hematocr | 1997 |
Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function.
Topics: Aging; Animals; Arginine; Body Weight; Cell Movement; Diet; Hemodynamics; Kidney; Kidney Glomerulus; | 1997 |
Glomerular basement membrane polyanionic sites and nitric oxide in genetically salt-sensitive and resistant hypertensive rats.
Topics: Animals; Basement Membrane; Creatinine; Drug Resistance; Hypertension; Kidney Glomerulus; Metabolic | 1997 |
Involvement of immunopathogenic mechanisms in a spontaneously occurring glomerulopathy in mice.
Topics: Animals; Blood Urea Nitrogen; Complement C3; Creatinine; Female; Glomerulosclerosis, Focal Segmental | 1998 |
Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Cell Extracts; Disease Models, Animal; Hydrogen | 1998 |
Experimental focal segmental glomerulosclerosis in mice.
Topics: Animals; Antibiotics, Antineoplastic; Cholesterol; Disease Models, Animal; Disease Progression; Doxo | 1998 |
Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Fructosamin | 1999 |
Analysis of nitric oxide in the exhaled air of patients with chronic glomerulonephritis.
Topics: Administration, Oral; Analysis of Variance; Anti-Inflammatory Agents; Case-Control Studies; Chronic | 1999 |
Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
Topics: Animals; Arginine; Culture Techniques; Dietary Proteins; Fibrosis; Glomerulonephritis; Kidney; Kidne | 2000 |
Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients.
Topics: Albuminuria; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; France; Hematuria; Hospitals, Un | 2001 |
The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats.
Topics: Aldosterone; Animals; Blood Pressure; Diet, Sodium-Restricted; Down-Regulation; Glucuronidase; Hyper | 2001 |
Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide.
Topics: Animals; Blood Pressure; Estradiol; Female; Glomerular Filtration Rate; Hemodynamics; Kidney; Nitrat | 2001 |
Johann Heller and the nitric acid ring test.
Topics: Austria; Chemistry, Clinical; Czechoslovakia; History, 19th Century; Nitrates; Nitric Acid; Philatel | 1988 |
Epithelial cell proliferation in the rat urinary system induced by parenteral injection of lead salts.
Topics: Animals; Cell Division; Electrophoresis, Polyacrylamide Gel; Epithelium; Kidney; Kidney Tubules, Pro | 1987 |
The precipitation of polymerized silicic acid by urine protein: a possible mechanism in the etiology of silica urolithiasis.
Topics: Animals; Cattle; Chemical Precipitation; Chlorides; Gelatin; Hydrogen-Ion Concentration; Nitrates; P | 1972 |
[The effect of basic diets on chronic uranylnitrate poisoning in rats].
Topics: Alkaline Phosphatase; Animal Nutritional Physiological Phenomena; Animals; Catalase; Erythrocyte Cou | 1971 |